The rush to control the COVID-19 pandemic has demonstrated that the global scientific community can tackle emergencies on a tight timeframe. In a matter of months, drugmakers have brought a host of ...
Staying inside increasingly narrow process windows as specialty devices scale, diversify, and enter high-volume production.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results